Search

Your search keyword '"Adams, Kirkwood F."' showing total 738 results

Search Constraints

Start Over You searched for: Author "Adams, Kirkwood F." Remove constraint Author: "Adams, Kirkwood F."
738 results on '"Adams, Kirkwood F."'

Search Results

1. The Effect of Omecamtiv Mecarbil in Hospitalized Patients as Compared With Outpatients With HFrEF: An Analysis of GALACTIC-HF

3. Omecamtiv Mecarbil in Black Patients With Heart Failure and Reduced Ejection Fraction: Insights From GALACTIC-HF

4. Neutrophil-to-Lymphocyte Ratio and Outcomes in Patients Admitted for Acute Heart Failure (As Seen in the BLAST-AHF, Pre-RELAX-AHF, and RELAX-AHF Studies)

5. Depressive symptoms are associated with clinical outcomes in heart failure with reduced ejection fraction.

6. Comparison of Hydralazine/Nitrate and Angiotensin Receptor Neprilysin Inhibitor Use Among Black Versus Nonblack Americans With Heart Failure and Reduced Ejection Fraction (from CHAMP-HF)

7. Charting a Roadmap for Heart Failure Biomarker Studies

8. Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions

9. Effective medications can work only in patients who take them: implications for post acute heart failure care

12. Association of Depression Symptoms and Biomarkers of Risk on Clinical Outcomes in HFrEF

16. Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial

18. Effective medications can work only in patients who take them: Implications for post‐acute heart failure care.

19. Efficacy of omecamtiv mecarbil in heart failure with reduced ejection fraction according to N‐terminal pro‐B‐type natriuretic peptide level: insights from the GALACTIC‐HF trial

25. Efficacy of omecamtiv mecarbil in heart failure with reduced ejection fraction according to N-terminal pro-B-type natriuretic peptide level: Insights from the GALACTIC-HF trial

27. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial

36. Phase III clinical trial end points in acute heart failure syndromes: A virtual roundtable with the acute heart failure syndromes international working group

42. Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction, GALACTIC‐HF: baseline characteristics and comparison with contemporary clinical trials

43. Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure

44. Relation of sex to morbidity and mortality in patients with heart failure and reduced or preserved left ventricular ejection fraction

47. Risk stratification for In-hospital mortality in acutely decompensated heart failure: Classification and regression tree analysis

48. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)

49. Heart rate: a prognostic factor and therapeutic target in chronic heart failure. The distinct roles of drugs with heart rate-lowering properties

50. Effects of tolvaptan a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial

Catalog

Books, media, physical & digital resources